December 2005
Worldwide Biotech;Dec2005, Vol. 17 Issue 12, p1
Trade Publication
Reports on an agreement forged by Chemicon International Inc. with Stem Cell Sciences Holdings LTD in December 2005, to develop embryonic stem cell media for the research market. Terms of the agreement; Background of the companies; Significance of the agreement to Chemicon.


Related Articles

  • Stem cell culture: New medium aids growth of embryonic stem cells.  // Pharmaceutical Technology Europe;Jun2006, Vol. 18 Issue 6, p15 

    The article reports that Stem Cell Sciences has launched the ESGRO complete clonal grade medium for culturing embryonic stem cells. The said medium contains recombinant murine leukemia inhibitory factor at a concentration sufficient to inhibit spontaneous differentiation and maintain the...

  • Stem Cell Research Emerges as a Novel New Tool in Biotechnology. Papanikolaw, Jim // Chemical Market Reporter;08/30/99, Vol. 256 Issue 9, p16 

    Focuses on stem cell research and a technology that offers the promise of treating diseases and tissue damage by using stem cells. Alliance between Rhone-Poulenc Rorer and Stem Cell Sciences (SCS) to use the gene and drug screening technology of SCS; Criticisms on the technology's use of adults...

  • Who but a fiend would cross pigs with men? Hunter, Ian // Report / Newsmagazine (National Edition);11/18/2002, Vol. 29 Issue 22, p24 

    Discusses genetic research with reference to advances in crossing humans and pigs. Mention of the American company Biotransplant and the Australian company Stem Cell Sciences; Statement that U.S. President George W. Bush put a ban on reproductive and research cloning; Discussion of moral and...

  • Embryonic business plan. Walters, Kath // BRW;3/29/2007, Vol. 29 Issue 12, p14 

    The article reports that Stem Cell Sciences (SCS) is hoping to raise between $10 million and $12 million from a public listing on the Australian Securities Exchange. SCS, a company specializing in embryonic stem cell therapy research, is also listed on the Alternative Investment Market and was...

  • Alastair Riddell.  // BRW;7/10/2008, Vol. 30 Issue 27, p62 

    The article presents an interview with Alastair Riddell, chief executive of Stem Cell Sciences. He recalls that when he arrived in Stem Cell Sciences, its stock price was declining and administrative costs surpassed those for research and development. He reveals that he was able to save the...

  • STEM CELL Industry Puts Scotland in the Spotlight.  // BioPharm International;Dec2006 Supplement, Vol. 19, p30 

    The article discusses the stem cell research industry in Scotland. This research has provided a platform for pioneering developments in stem cell biology and regenerative medicine research. Stem Cell Sciences Ltd., CXR Biosciences and Angel Biotechnology are examples of companies conducting...

  • Raman Chemical Imaging Microscope.  // Laboratory Equipment;Oct2001, Vol. 38 Issue 6, p1 

    Introduces Falcon Raman Chemical Imaging Microscope from ChemIcon Inc. in Pittsburgh, Pennsylvania. Combination of molecular spectroscopy and digital imaging; Features of the imaging microscope; Advancement in data processing and visualization.

  • Research & Markets: Stem Cells Research - 2011 Global Strategic Business Report.  // Biomedical Market Newsletter;5/21/2011, p965 

    The article lists several companies included in the report analyzing the market for stem cells research in the U.S.

  • FALCON Designed for Speed.  // R&D Magazine;Sep2001, Vol. 43 Issue 9, p61 

    Focuses on the FALCON Raman Chemical Imaging Microscope developed by ChemIcon Inc. Features of the microscope.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics